These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37819517)

  • 1. The Pseudomonas aeruginosa Resistome: Permanent and Transient Antibiotic Resistance, an Overview.
    Sanz-García F; Laborda P; Ochoa-Sánchez LE; Martínez JL; Hernando-Amado S
    Methods Mol Biol; 2024; 2721():85-102. PubMed ID: 37819517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic Resistance in Pseudomonas.
    Laborda P; Hernando-Amado S; Martínez JL; Sanz-García F
    Adv Exp Med Biol; 2022; 1386():117-143. PubMed ID: 36258071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Habitat-Dependent Antibiotic Resistance in Pseudomonas aeruginosa.
    Laborda P; Martínez JL; Hernando-Amado S
    Microbiol Spectr; 2022 Aug; 10(4):e0024722. PubMed ID: 35766499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa.
    Jaillard M; van Belkum A; Cady KC; Creely D; Shortridge D; Blanc B; Barbu EM; Dunne WM; Zambardi G; Enright M; Mugnier N; Le Priol C; Schicklin S; Guigon G; Veyrieras JB
    Int J Antimicrob Agents; 2017 Aug; 50(2):210-218. PubMed ID: 28554735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.
    Sherrard LJ; Tai AS; Wee BA; Ramsay KA; Kidd TJ; Ben Zakour NL; Whiley DM; Beatson SA; Bell SC
    PLoS One; 2017; 12(3):e0172179. PubMed ID: 28273168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in
    Jorth P; McLean K; Ratjen A; Secor PR; Bautista GE; Ravishankar S; Rezayat A; Garudathri J; Harrison JJ; Harwood RA; Penewit K; Waalkes A; Singh PK; Salipante SJ
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intrinsic resistome of Pseudomonas aeruginosa to β-lactams.
    Alvarez-Ortega C; Wiegand I; Olivares J; Hancock RE; Martínez JL
    Virulence; 2011; 2(2):144-6. PubMed ID: 21304266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPM-1-producing Pseudomonas aeruginosa ST277 carries a chromosomal pack of acquired resistance genes: An example of high-risk clone associated with 'intrinsic resistome'.
    Galetti R; Andrade LN; Varani AM; Darini ALC
    J Glob Antimicrob Resist; 2019 Mar; 16():183-186. PubMed ID: 30586621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TpiA is a Key Metabolic Enzyme That Affects Virulence and Resistance to Aminoglycoside Antibiotics through CrcZ in Pseudomonas aeruginosa.
    Xia Y; Wang D; Pan X; Xia B; Weng Y; Long Y; Ren H; Zhou J; Jin Y; Bai F; Cheng Z; Jin S; Wu W
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Pseudomonas aeruginosa genes associated with antibiotic susceptibility.
    Chen L; Yang L; Zhao X; Shen L; Duan K
    Sci China Life Sci; 2010 Oct; 53(10):1247-51. PubMed ID: 20953948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the evolution of the mutational resistome of Pseudomonas aeruginosa in cystic fibrosis.
    López-Causapé C; Oliver A
    Future Microbiol; 2017 Dec; 12():1445-1448. PubMed ID: 29068237
    [No Abstract]   [Full Text] [Related]  

  • 12. The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia.
    Law JP; Wood AJ; Friman VP
    Microbiol Spectr; 2022 Dec; 10(6):e0184222. PubMed ID: 36453898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of Antibiotic Tolerance Shapes Resistance Development in Chronic Pseudomonas aeruginosa Infections.
    Santi I; Manfredi P; Maffei E; Egli A; Jenal U
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis.
    Cortes-Lara S; Barrio-Tofiño ED; López-Causapé C; Oliver A;
    Clin Microbiol Infect; 2021 Nov; 27(11):1631-1637. PubMed ID: 34015532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution.
    Botelho J; Grosso F; Peixe L
    Drug Resist Updat; 2019 May; 44():100640. PubMed ID: 31492517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa.
    Cardozo C; Rico V; Agüero D; Soriano A
    Rev Esp Quimioter; 2019 Sep; 32 Suppl 2(Suppl 2):32-34. PubMed ID: 31475807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.
    Colque CA; Albarracín Orio AG; Feliziani S; Marvig RL; Tobares AR; Johansen HK; Molin S; Smania AM
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071060
    [No Abstract]   [Full Text] [Related]  

  • 18. Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomes.
    Madden DE; Baird T; Bell SC; McCarthy KL; Price EP; Sarovich DS
    Genome Med; 2024 Jun; 16(1):78. PubMed ID: 38849863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.
    Martin LW; Robson CL; Watts AM; Gray AR; Wainwright CE; Bell SC; Ramsay KA; Kidd TJ; Reid DW; Brockway B; Lamont IL
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.